PLUR
Pluri Inc.Company Information
- Company Name
- Pluri Inc.
- CIK
- CIK0001158780
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PLUR: Nasdaq
- Fiscal Year End
- June 30
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- PLUR
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-04-28
- Last sale
- 2022-12-20
- Shares purchased (TTM)
- 1,428,841
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 26,466
- Shares outstanding
- 9,743,913
- Ownership
- 0.27%
Earnings Market Reaction
- Filing date
- 2026-09-10
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 4 | 3 | 5 | 4 | 6 | 8 | 7 | 3 | 7 | 7 | 5 | 5 | ||||||
| Deposits Assets Current | 4 | 6 | 8 | 11 | 15 | 18 | 14 | - | 23 | - | - | - | ||||||
| Restricted Cash Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Receivables From Customers | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | - | ||||||
| Restricted Cash | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets Current | 9 | 10 | 14 | 17 | 22 | 27 | 22 | 27 | 31 | 27 | 32 | 35 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Restricted Cash Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Defined Benefit Plan Assets For Plan Benefits Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 2 | - | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | 3 | 3 | 3 | - | - | - | - | - | - | - | ||||||
| Goodwill | 3 | 3 | 3 | 3 | 3 | - | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 6 | 6 | 7 | 7 | 7 | 7 | 6 | 6 | 7 | 7 | 7 | 7 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Noncurrent | 16 | 16 | 17 | 17 | 17 | 10 | 8 | 8 | 8 | 9 | 9 | 9 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Assets | 25 | 26 | 31 | 34 | 39 | 37 | 31 | 35 | 40 | 36 | 42 | 45 | ||||||
Liabilities Current | ||||||||||||||||||
| Warrants And Rights Outstanding | - | - | - | - | - | 0 | - | - | - | - | - | - | ||||||
| Accounts Payable Trade Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Customer Advances Current | - | - | - | - | - | - | - | - | - | 0 | - | - | ||||||
| Loans Payable To Bank Current | 27 | 27 | 28 | 28 | 27 | - | - | - | - | - | - | - | ||||||
| Accounts Payable Other Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 33 | 32 | 32 | 32 | 32 | 6 | 4 | 5 | 4 | 5 | 5 | 4 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Postemployment Benefits Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Noncurrent | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
Share Capital | ||||||||||||||||||
| Long Term Loans From Bank | - | - | - | - | - | - | - | - | 24 | - | - | - | ||||||
| Other Long Term Debt Noncurrent | - | - | - | - | - | 25 | 24 | 25 | 24 | 24 | 24 | 23 | ||||||
| Deferred Income Tax Liabilities Net | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Preferred Stock Value | - | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities Noncurrent | 10 | 7 | 7 | 7 | 7 | 31 | 29 | 31 | 30 | 30 | 30 | 29 | ||||||
| Additional Paid In Capital Common Stock | - | 442 | 441 | 438 | 436 | 431 | 421 | 421 | 421 | 414 | 414 | 413 | ||||||
| Retained Earnings Accumulated Deficit | -467 | -461 | -455 | -449 | -443 | -435 | -429 | -426 | -420 | -415 | -409 | -405 | ||||||
| Stockholders Equity | -17 | -13 | -9 | -11 | -1 | 0 | -3 | -0 | 0 | -0 | 4 | 9 | ||||||
| Minority Interest | 6 | 6 | 5 | 6 | 6 | 5 | 5 | 5 | 5 | 2 | 2 | 2 | ||||||
| Liabilities And Stockholders Equity | 25 | 26 | 31 | 34 | 39 | 37 | 31 | 35 | 40 | 36 | 42 | 45 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 38 | 38 | 38 | 38 | 38 | 38 | 38 | 38 | 38 | 38 | 300 | 300 | ||||||
| Common Stock Shares Issued | 11 | 10 | 10 | 8 | 8 | 8 | 6 | 6 | 5 | 5 | 5 | 5 | ||||||
| Shares Outstanding | 11 | 10 | 10 | 8 | 8 | 8 | 6 | 6 | 5 | 5 | 5 | 5 | ||||||
Select a line item above to chart it.
Recent filings
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPluri Inc. (PLUR) — SEC Financial Statements & Analysis
Pluri Inc. (PLUR) is a biological products, (no diagnostic substances) company, incorporated in NV. Pluri Inc. trades on Nasdaq as: PLUR. Pluri Inc. (PLUR)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-09-10. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Pluri Inc. carries a market cap of $20.36M, a P/E ratio of -0.80x, a P/B ratio of -1.17x, a P/S ratio of 20.04x, an enterprise value of $15.79M, and an EV/EBITDA multiple of -0.64x. On profitability, it posts a gross margin of 44.59%, an operating margin of -2454.53%, a net margin of -2496.95%, a Return on Equity (ROE) of 277.27%, a Return on Assets (ROA) of -79.83%, and a Return on Invested Capital (ROIC) of -303.88%. Per share, it reports EPS of $-2.60, diluted EPS of $-2.60, free cash flow per share of $-2.08, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -23.95% year-over-year, net income growth of 12.34% year-over-year, and EPS growth of -26.94% year-over-year. On the balance sheet, it maintains a current ratio of 0.27x, a quick ratio of 0.24x, working capital of $-23.99M, a debt-to-equity ratio of -2.43x, a debt ratio of 1.7, an interest coverage ratio of -26.76x, free cash flow of $-20.22M (TTM), and net debt of $-4.58M. Figures sourced from SEC EDGAR.
- Market Cap
- $20.36M
- P/E TTM
- -0.80x
- EPS TTM
- $-2.60
- P/B TTM
- -1.17x
- ROE TTM
- 277.27%
- ROA TTM
- -79.83%
- Debt To Equity
- -2.43x
- Free Cash Flow TTM
- $-20.22M
- Net Revenue TTM Growth 1Y
- -23.95%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Pluri Inc. in?
Pluri Inc. (PLUR) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does PLUR trade on?
Pluri Inc. (PLUR) trades on the Nasdaq.
Where is Pluri Inc. incorporated?
Pluri Inc. is incorporated in NV.
When was Pluri Inc. (PLUR)'s most recent SEC filing?
Pluri Inc. (PLUR)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-09-10.
What is PLUR's market cap?
Pluri Inc. (PLUR) has a market capitalization of $20.36M as of 2026-06-30.
What is PLUR's EPS (earnings per share)?
Pluri Inc. (PLUR)'s trailing twelve month EPS is $-2.60 as of 2026-06-30.
What is PLUR's ROE (return on equity)?
Pluri Inc. (PLUR)'s trailing twelve month Return on Equity (ROE) is 277.27% as of 2026-06-30.
What is PLUR's ROA (return on assets)?
Pluri Inc. (PLUR)'s trailing twelve month Return on Assets (ROA) is -79.83% as of 2026-06-30.
What is PLUR's ROIC (return on invested capital)?
Pluri Inc. (PLUR)'s trailing twelve month Return on Invested Capital (ROIC) is -303.88% as of 2023-09-30.
What is PLUR's EV/EBITDA?
Pluri Inc. (PLUR)'s trailing twelve month EV/EBITDA is -0.64x as of 2026-06-30.